
Trumpās Drug Tariffs: Price Cuts or Pipeline Risks?
U.S. President Trumpās threatened pharma tariffs have spurred over $250 billion in planned U.S. investmentsābut experts warn higher domestic costs and global supply chains may keep prices high.